Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Revive: Redasemtide in Acute Ischemic Stroke
NCT05953480Phase 2Completed
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Jul 2023
- Primary completion
- Jun 2026
- Modality
- Peptides
- Countries
- 17
01
Overview
A Phase 2 trial of redasemtide in ischemic stroke, sponsored by Shionogi & Co., Ltd.. Started Jul 2023; status: completed.
02
Drugs
redasemtide
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT05953480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05953480.